Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia (Q24246397)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

0 references

1 reference

title

Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

0 references

1 reference

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

A Dewey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

C Baughan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

B Higgins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

I Johnson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

24 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

CD004597

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Nutritional approach in malnourished surgical patients: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Complications of pancreatic surgery and the role of perioperative nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Preoperative oral supplement with immunonutrients in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

n-3 versus n-6 polyunsaturated fatty acids in critical illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Influence of a pre-operative enteral supplement on functional activities of peripheral leukocytes from patients with major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Nutritional and metabolic assessment of the hospitalized patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Body composition measurement: a review of hydrodensitometry, anthropometry, and impedance methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Bioelectrical impedance analysis--part I: review of principles and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Meanings of the phenomenon of fatigue as narrated by 4 patients with cancer in palliative care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Cancer cachexia: effects of the disease and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Mechanism of muscle protein degradation in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004597.PUB2

Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial

21 January 2018

1 reference

12 December 2020

Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer.

1 reference

12 December 2020

Reduced postoperative infections with an immune-enhancing nutritional supplement

1 reference

12 December 2020

A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional status

1 reference

12 December 2020

Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study

1 reference

12 December 2020

Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473.

1 reference

12 December 2020

Increased survival in brain metastatic patients treated with stereotactic radiotherapy, omega three fatty acids and bioflavonoids

1 reference

12 December 2020

Supplementation with key nutrients reduced postoperative infections and length of hospital stay after gastrointestinal surgery

1 reference

12 December 2020

Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome

1 reference

12 December 2020

1 reference

12 December 2020

Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover

1 reference

12 December 2020

Prednisolone as an appetite stimulant in patients with cancer

1 reference

12 December 2020

Hyperalimentation of the cancer patient with protein-calorie undernutrition

1 reference

12 December 2020

Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer

1 reference

12 December 2020

Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients

1 reference

12 December 2020

Polyunsaturated fatty acids in the treatment of weight-losing patients with pancreatic cancer.

1 reference

12 December 2020

Comparison of the effectiveness of eicosapentaenoic acid administered as either the free acid or ethyl ester as an anticachectic and antitumour agent

1 reference

12 December 2020

Immune and nutritional effects of early enteral nutrition after major abdominal operations

1 reference

12 December 2020

Induction of muscle protein degradation and weight loss by a tumor product

1 reference

12 December 2020

Food intake and body composition in cancer cachexia

1 reference

12 December 2020

The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer

1 reference

12 December 2020

Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia

1 reference

12 December 2020

Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions

1 reference

12 December 2020

Benefits of early postoperative enteral feeding in cancer patients

1 reference

12 December 2020

Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enteral formulas

1 reference

12 December 2020

Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6

1 reference

12 December 2020

Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients

1 reference

12 December 2020

[The effect of the composition of the enteral nutrition on infection in the critical patient]

1 reference

12 December 2020

Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery

1 reference

12 December 2020

A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy

1 reference

12 December 2020

Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms

1 reference

12 December 2020

Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial

1 reference

12 December 2020

A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy's Hospital Intensive Care Group

1 reference

12 December 2020

10.1002/14651858.CD004597.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

5096364

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

24 December 2019

5096364

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253515%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference